中东和非洲无活动膀胱市场规模和行业关键参与者

中东和非洲膀胱功能低下市场

中东和非洲膀胱功能低下市场分析与洞察

中东和非洲膀胱功能低下市场受到多种因素的推动，例如神经源性膀胱感染发病率上升、研究资金增加、膀胱功能低下 (UAB) 新疗法的开发、产品线的不断完善以及研发投资的增加，这些因素都推动了市场增长。目前，发达国家和新兴国家的医疗保健支出都有所增加，这有望为制造商开发新的创新产品创造竞争优势。此外，医疗保健支出的激增和膀胱疾病患病率的上升也对市场产生了积极影响。

中东和非洲膀胱功能低下市场

然而，高昂的治疗费用限制了患者接受高质量、有效的治疗方案。因此，高昂的治疗程序费用对整体治疗成本产生了负面影响。此外，目前用于治疗 UAB 的药物在有效性和安全性方面尚未得到临床证实，因此需要开发新的治疗药物。

由于市场参与者的增加和新型药物的出现，中东和非洲膀胱功能低下市场预计在预测期内将增长。与此同时，制造商正在开展研发活动，以向市场推出新产品。

然而，预计与研究和调查相关的高成本将抑制市场增长，从而进一步影响新产品的上市。

研发项目数量的增加以及为促进创新有效治疗的新发展而建立的公私合作伙伴关系的兴起进一步影响了市场。

中东和非洲膀胱功能低下市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入来源、市场法规变化、产品批准、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情景，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。各地区发展中国家零售单位的可扩展性和业务扩展以及与供应商合作安全分销机器和药品是推动预测期内市场需求的主要驱动力。

中东和非洲膀胱功能低下市场具有支持性，旨在减缓疾病的进展。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，中东和非洲膀胱功能低下市场将以 3.5% 的复合年增长率增长。

报告指标	细节
预测期	2022 至 2029 年
基准年	2021
历史岁月	2020
定量单位	收入（百万美元），定价（美元）
涵盖的领域	按类型（药物治疗、外科手术方法、尿道辅助装置、干细胞和基因疗法）、给药途径（口服、肠外和其他）、最终用户（医院、诊所、学术和研究机构和其他）、分销渠道（医院药房、零售药房和其他）
覆盖国家	沙特阿拉伯、南非、阿联酋、以色列、科威特、埃及以及中东和非洲其他地区
涵盖的市场参与者	Astellas Pharma Inc.、Aurobindo Pharma.、Boehringer Ingelheim International GmbH、Macleods Pharmaceuticals Ltd.、Orion Corporation、Novartis AG、Pfizer Inc.、Cipla Inc.、Teva Pharmaceutical Industries Ltd.、Sun Pharmaceutical Industries Ltd.、Almirall, SA 和 Alkem Labs. 等

市场定义

膀胱活动不足（UAB）是一种临床病症，由于排尿时逼尿肌（膀胱逼尿肌）收缩减少而出现排尿障碍。其特征是立即有尿意，因此，该病症与膀胱过度活动症不同。本发明提供了一种可用于预防或治疗 UAB 的药物组合物，其具有改善尿流率的效果、改善膀胱过度扩张的效果（减少膀胱容量的效果），因此可用于预防或治疗 UAB。

而且，这是一种与近年来备受关注的以尿急为特征的膀胱过度活动症不同的疾病状态。UAB 的原因包括糖尿病和酒精中毒等自主神经病变、根治性子宫切除术和根治性直肠癌等盆腔手术、脊柱裂等脊髓疾病，并且还已知椎间盘突出症。患有严重和轻微膀胱疾病相关问题的患者需要药物治疗，通常需要多种疗法循环，并且如果得不到充分缓解，则需要继续治疗，这也对医疗费用造成影响。

中东和非洲膀胱功能低下市场动态

本节旨在了解市场驱动因素、机遇、限制因素和挑战。下面将详细讨论所有这些内容：

驱动程序

神经系统疾病患病率不断上升

UAB 是一种常见的神经系统疾病，神经和肌肉无法很好地协同工作，导致排尿时间延长，有时伴有膀胱排空不完全的感觉。在这种情况下，逼尿肌的收缩活动能力不佳，其特征是尿流缓慢、排尿犹豫和排尿费力，有时伴有膀胱排空不完全的感觉，有时甚至伴有储尿症状。因此，膀胱无法排空或仅部分排空，这是由于膀胱肌肉无法正常排尿造成的。

因此，UAB 患者可能出现各种排尿症状，并可能伴有大量残留尿。由于病情加重而导致的尿潴留并发症和由于长期残留尿导致的尿路感染 (UTI) 很常见，并且已成为一个问题。此外，这是一种与近年来备受关注的以尿急为特征的 OAB 不同的疾病状态。因此，神经源性膀胱疾病的患病率不断上升预计将推动市场增长。这将导致对能够检测患者的治疗的需求增加，因此市场将有望实现丰厚的增长。

医疗支出上涨

仪器、人力、医疗管理（以防研究人员受到伤害）、保险、运输、伦理委员会费用、数据处理和其他消耗品，导致市场参与者承担大量成本。医疗保健支出包括所有医疗保健服务、检测设备、计划生育活动和指定用于健康的紧急援助。国家卫生账户根据在国际公认框架内收集的支出提供许多指标。决定任何国家医疗保健支出的因素是收入（人均 GDP）、技术进步和医疗实践差异以及卫生系统特征。

医疗保健支出的增加同时有助于医疗保健组织和政府机构增加对更年期药物的研究活动、即将进行的临床试验和研发活动。此外，由于新产品的生产和制造成本，市场参与者需要充足的资金和资源分配，因此，政府在这种情况下起到了帮助作用。不断增长的医疗保健支出也有利于进一步的经济发展和医疗保健行业的增长。此外，人口可支配收入的增加也是一个有利因素。因此，预计医疗保健支出的增加将在未来推动市场增长。

机会

糖尿病泌尿系统并发症增多

已知的 UAB 病因之一包括自主神经病变，例如糖尿病。此外，糖尿病与泌尿系统疾病的早期发病和严重程度增加有关，从而导致代价高昂且令人衰弱的泌尿系统并发症。这些泌尿系统并发症，包括膀胱功能障碍和尿路感染等，对糖尿病男性和女性的生活质量有着深远的影响。糖尿病和泌尿系统疾病是非常常见的健康问题，随着年龄的增长，患病率和发病率显著增加。糖尿病的泌尿系统并发症是直接影响。糖尿病是最突出的疾病，全球患病率很高。

糖尿病相关的膀胱并发症可能是由于逼尿肌平滑肌交替、神经功能障碍和尿路上皮功能障碍引起的。根据所涉及的神经，糖尿病神经病变的影响范围从腿部不适和麻木到消化系统、泌尿道、血管和核心并发症。糖尿病数据的增加将显著增加全球糖尿病泌尿系统并发症的风险。因此，需要为正确治疗糖尿病泌尿系统并发症推荐未来的研究和临床护理方向。还需要其他组织的支持，以覆盖欠发达地区，解决被忽视的并发症。因此，这意味着糖尿病泌尿系统并发症的增加有望成为市场增长的机会。

克制/挑战

研发成本高

研发是修改治疗不同类型患者的程序的先决条件。新产品的研发成本较高，需要深入的研究和临床研究。研发的各个临床阶段都需要巨额投资，这可能会影响市场增长。研究成本涉及研究的规划和执行，而研究需要充足的资金和资源分配，这可能会影响市场的新发展。产品成本在市场上起着重要作用。市场上有许多诊断选择，但由于成本高昂，大多数人往往避免进行诊断。诊断方法的灵敏度和特异性更高，测试成本也随之增加。

该程序的高成本是由于治疗的多个检查点以及使用高科技方式执行此类程序。由于治疗的研发成本过高，限制了提供高质量和有效的解决方案。因此，高成本对整体治疗成本产生负面影响。因此，它将限制未来中低收入国家对治疗的需求。这表明，与研究和调查相关的高成本预计将抑制市场增长，从而进一步影响新产品在市场上的推出。

COVID-19 对中东和非洲膀胱活动不足市场的影响

COVID-19 对市场增长产生了积极影响，因为该地区对产品的需求普遍增加。随着该地区各种膀胱疾病的患病率不断上升，人们的健康意识也越来越强。由于病情加重而导致的尿潴留并发症和由于长期残留尿液而导致的尿路感染很常见，这已成为一个问题。因此，COVID-19 对这个市场产生了积极影响。

最新动态

2020 年 6 月，Vesiflo, Inc. 宣布 inFlow 尿道假体纳入医保范围，这是一种经 FDA 批准的磁耦合尿道内瓣膜泵装置，可供成年女性使用 29 天，作为间歇性导尿的替代方案。这有助于产品业务的快速扩张，并实现市场商业化。
2020 年 4 月，安斯泰来制药欧洲有限公司完成了一项针对膀胱活动性功能低下患者的临床试验。目前，ASP8302 正在进行 2 期临床试验，以研究该药物对膀胱活动性功能低下患者的安全性和耐受性。

中东和非洲膀胱功能低下市场范围

根据类型、给药途径、最终用户和分销渠道，中东和非洲膀胱功能低下市场可分为四个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

类型

药物治疗
手术方法
尿道辅助装置
干细胞和基因疗法

根据类型，市场分为药物治疗、手术方法、尿道辅助装置以及干细胞和基因疗法。

给药途径

口服
肠外
其他的

根据给药途径，市场分为口服、肠外和其他。

最终用户

医院
诊所
学术及研究机构
其他的

根据最终用户，市场分为医院、诊所、学术和研究机构等。

分销渠道

医院药房
零售药店
其他的

膀胱活动不足市场

根据分销渠道，市场分为医院药房、零售药房和其他。

中东和非洲膀胱功能低下市场区域分析/见解

对中东和非洲膀胱活动不足市场进行了分析，并按类型、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。

中东和非洲膀胱功能低下市场报告涉及的国家包括沙特阿拉伯、南非、阿联酋、以色列、科威特、埃及以及中东和非洲的其他国家。

2022 年，中东和非洲膀胱功能低下市场预计将因膀胱疾病患病率上升和老年人口增长而增长。膀胱疾病治疗技术的进步和产品批准的增加也推动了市场增长。

由于拥有庞大的市场参与者和完善的治疗膀胱疾病的医疗保健体系，南非预计将占据主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了中东和非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和中东和非洲膀胱活动不足市场份额分析

中东和非洲膀胱功能低下市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、中东和非洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对中东和非洲膀胱功能低下市场的关注有关。

一些市场参与者

安斯泰来制药公司
奥罗宾多制药公司
勃林格殷格翰国际有限公司
麦克劳德制药有限公司
猎户座公司
诺华公司
辉瑞公司
西普拉公司
梯瓦制药工业有限公司
太阳制药工业有限公司
阿尔米拉尔, SA
Alkem 实验室。

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、中东和非洲与国家/地区以及供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-69096

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 TOTAL 40 DOXAZOSIN DRUGS WERE DISCONTINUED FROM THE MARKET

TABLE 2 TOTAL 38 DOXAZOSIN DRUGS ARE STILL IN THE MARKET

TABLE 3 TOTAL PRESCRIPTION AND DISCONTINUED DRUGS (DOXAZOSIN) BY COMPANY

TABLE 4 TOTAL 58 DRUGS DISCONTINUED

TABLE 5 TOTAL PRESCRIPTION AND DISCONTINUED DRUGS (BETHANECHOL CHLORIDE) BY COMPANY

TABLE 6 OUT OF 3,128 STUDIES ON BLADDER DISORDER, ONLY 22 STUDIES ARE ONGOING FOR THE UAB-

TABLE 7 THESE CLINICAL TRIALS ARE MOSTLY RECRUITING/ONGOING IN DIFFERENT REGIONS OF THE WORLD-

TABLE 8 TOP ACQUISITIONS OF 2021 RANKED BY TOTAL DEAL VALUE:

TABLE 9 FDA REQUIRES THE FOLLOWING SCENARIO BEFORE A DRUG IS APPROVED

TABLE 10 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET, TYPE, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA BY PRODUCT TYPE IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA BRANDED IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA SURGICAL METHODS IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA SURGICAL METHODS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA URETHRAL ASSIS DEVICE IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA URETHRAL ASSIS DEVICE IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA STEM CELL AND GENE THERAPIES IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA STEM CELL AND GENE THERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET , BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA PARENTERAL IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA ORAL IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA OTHERS IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET , BY END USER, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA HOSPITALS IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA CLINICS IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA OTHERS IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET , BY DISTRIBUTION CHANNEL , 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA HOSPITAL PHARMACY IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA RETAIL PHARMACY IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA OTHERS IN UNDERACTIVE BLADDER MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA UNDERACTIVE BLADDER MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 42 MIDDLE EAST AND AFRICA BY DRUGS UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 43 MIDDLE EAST AND AFRICA BY PRODUCT TYPE UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 46 MIDDLE EAST AND AFRICA BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 47 MIDDLE EAST AND AFRICA SURGICAL METHODS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA URETHRAL ASSIS DEVICE IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA STEM CELL AND GENE THERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA UNDERACTIVE BLADDER MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA UNDERACTIVE BLADDER MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 52 MIDDLE EAST AND AFRICA UNDERACTIVE BLADDER MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 53 SOUTH AFRICA UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 SOUTH AFRICA PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 55 SOUTH AFRICA PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 SOUTH AFRICA BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 57 SOUTH AFRICA BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 58 SOUTH AFRICA BY DRUGS UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 59 SOUTH AFRICA BY PRODUCT TYPE UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 SOUTH AFRICA BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 61 SOUTH AFRICA BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 62 SOUTH AFRICA BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 63 SOUTH AFRICA SURGICAL METHODS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 64 SOUTH AFRICA URETHRAL ASSIS DEVICE IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 65 SOUTH AFRICA STEM CELL AND GENE THERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 66 SOUTH AFRICA UNDERACTIVE BLADDER MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 67 SOUTH AFRICA UNDERACTIVE BLADDER MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 68 SOUTH AFRICA UNDERACTIVE BLADDER MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 69 SAUDI ARABIA UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 70 SAUDI ARABIA PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 71 SAUDI ARABIA PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 72 SAUDI ARABIA BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 73 SAUDI ARABIA BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 74 SAUDI ARABIA BY DRUGS UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 75 SAUDI ARABIA BY PRODUCT TYPE UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 SAUDI ARABIA BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 SAUDI ARABIA BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 78 SAUDI ARABIA BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 79 SAUDI ARABIA SURGICAL METHODS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 80 SAUDI ARABIA URETHRAL ASSIS DEVICE IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 81 SAUDI ARABIA STEM CELL AND GENE THERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 82 SAUDI ARABIA UNDERACTIVE BLADDER MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 83 SAUDI ARABIA UNDERACTIVE BLADDER MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 84 SAUDI ARABIA UNDERACTIVE BLADDER MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 85 U.A.E UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 86 U.A.E PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 87 U.A.E PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 88 U.A.E BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 89 U.A.E BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 90 U.A.E BY DRUGS UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 91 U.A.E BY PRODUCT TYPE UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 92 U.A.E BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 93 U.A.E BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 94 U.A.E BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 95 U.A.E SURGICAL METHODS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 96 U.A.E URETHRAL ASSIS DEVICE IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 97 U.A.E STEM CELL AND GENE THERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 U.A.E UNDERACTIVE BLADDER MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 99 U.A.E UNDERACTIVE BLADDER MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 100 U.A.E UNDERACTIVE BLADDER MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 101 ISRAEL UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 ISRAEL PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 ISRAEL PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 ISRAEL BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 105 ISRAEL BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 106 ISRAEL BY DRUGS UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 107 ISRAEL BY PRODUCT TYPE UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 108 ISRAEL BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 109 ISRAEL BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 110 ISRAEL BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 111 ISRAEL SURGICAL METHODS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 112 ISRAEL URETHRAL ASSIS DEVICE IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 113 ISRAEL STEM CELL AND GENE THERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 114 ISRAEL UNDERACTIVE BLADDER MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 115 ISRAEL UNDERACTIVE BLADDER MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 116 ISRAEL UNDERACTIVE BLADDER MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 117 EGYPT UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 118 EGYPT PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 119 EGYPT PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 120 EGYPT BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 121 EGYPT BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 122 EGYPT BY DRUGS UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 123 EGYPT BY PRODUCT TYPE UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 EGYPT BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 125 EGYPT BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 126 EGYPT BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 127 EGYPT SURGICAL METHODS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 128 EGYPT URETHRAL ASSIS DEVICE IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 129 EGYPT STEM CELL AND GENE THERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 130 EGYPT UNDERACTIVE BLADDER MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 131 EGYPT UNDERACTIVE BLADDER MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 132 EGYPT UNDERACTIVE BLADDER MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 133 KUWAIT UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 134 KUWAIT PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 135 KUWAIT PHARMACOTHERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 136 KUWAIT BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 137 KUWAIT BY DRUGS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 138 KUWAIT BY DRUGS UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 139 KUWAIT BY PRODUCT TYPE UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 140 KUWAIT BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 141 KUWAIT BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 142 KUWAIT BRANDED UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 143 KUWAIT SURGICAL METHODS IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 144 KUWAIT URETHRAL ASSIS DEVICE IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 145 KUWAIT STEM CELL AND GENE THERAPY IN UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 146 KUWAIT UNDERACTIVE BLADDER MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 147 KUWAIT UNDERACTIVE BLADDER MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 148 KUWAIT UNDERACTIVE BLADDER MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 149 REST OF MIDDLE EAST AND AFRICA UNDERACTIVE BLADDER MARKET, BY TYPE, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET: SEGMENTATION

FIGURE 11 INCREASING PREVALENCE OF NEUROGENIC BLADDER INFECTIONS IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET IN THE FORECAST PERIOD

FIGURE 12 TREATMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET

FIGURE 14 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : TYPE, 2021

FIGURE 15 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : TYPE, 2022-2029 (USD MILLION)

FIGURE 16 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : TYPE, CAGR (2022-2029)

FIGURE 17 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : TYPE, LIFELINE CURVE

FIGURE 18 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY ROUTE OF ADMINISTRATION, 2021

FIGURE 19 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION)

FIGURE 20 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)

FIGURE 21 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 22 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY END USER, 2021

FIGURE 23 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY END USER, 2022-2029 (USD MILLION)

FIGURE 24 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY END USER, CAGR (2022-2029)

FIGURE 25 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY END USER, LIFELINE CURVE

FIGURE 26 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY DISTRIBUTION CHANNEL, 2021

FIGURE 27 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 28 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 29 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 30 MIDDLE EAST AND AFRICA UNDERACTIVE BLADDER MARKET: SNAPSHOT (2021)

FIGURE 31 MIDDLE EAST AND AFRICA UNDERACTIVE BLADDER MARKET: BY COUNTRY (2021)

FIGURE 32 MIDDLE EAST AND AFRICA UNDERACTIVE BLADDER MARKET: BY COUNTRY (2022 & 2029)

FIGURE 33 MIDDLE EAST AND AFRICA UNDERACTIVE BLADDER MARKET: BY COUNTRY (2021 & 2029)

FIGURE 34 MIDDLE EAST AND AFRICA UNDERACTIVE BLADDER MARKET: BY TYPE (2022-2029)

FIGURE 35 MIDDLE EAST & AFRICA UNDERACTIVE BLADDER MARKET: COMPANY SHARE 2021 (%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

What is the growth rate of the Market?

Middle East and Africa Underactive Bladder Market will grow at a CAGR of 3.5% during the forecast by 2029.

Which factors are poised to restrict the market growth?

The higher cost of R&D for new products demands deep research and clinical studies. The various clinical phases in R&D require huge investments which can affect Middle East and Africa Underactive Bladder Market growth.

Who are the major players operating in the market?

The major players operating in the Middle East and Africa Underactive Bladder Market are Astellas Pharma Inc., Aurobindo Pharma., Boehringer Ingelheim International GmbH, Macleods Pharmaceuticals Ltd., Orion Corporation, Novartis AG, Pfizer Inc., Cipla Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Almirall, S.A, and Alkem Labs. among others.

What are the major countries covered in the Market?

The major countries covered in the Middle East and Africa Underactive Bladder Market are Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, and rest of Middle East and Africa.

中东和非洲膀胱功能低下市场 – 行业趋势和 2029 年预测

中东和非洲膀胱功能低下市场 – 行业趋势和 2029 年预测

中东和非洲膀胱功能低下市场分析与洞察

中东和非洲膀胱功能低下市场动态

COVID-19 对中东和非洲膀胱活动不足市场的影响

中东和非洲膀胱功能低下市场范围

中东和非洲膀胱功能低下市场区域分析/见解

竞争格局和中东和非洲膀胱活动不足市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

报告

市场洞察

支持

解决方案

中东和非洲膀胱功能低下市场 – 行业趋势和 2029 年预测

中东和非洲膀胱功能低下市场 – 行业趋势和 2029 年预测

中东和非洲膀胱功能低下市场分析与洞察

中东和非洲膀胱功能低下市场动态

COVID-19 对中东和非洲膀胱活动不足市场的影响

中东和非洲膀胱功能低下市场范围

中东和非洲膀胱功能低下市场区域分析/见解

竞争格局和中东和非洲膀胱活动不足市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

浏览相关页面